MintzEdge 101: FDA For Start-Ups

In this episode of MintzEdge’s From the Edge podcast, Sam Effron speaks with Ben Zegarelli of Mintz about considerations for new medical device, pharmaceutical, or other health regulated start-ups and strategies for how to prepare for FDA oversight.

Subscribe

Sam Effron

Here’s the beauty of working with start-ups: I get to collaborate with people who see things from fresh perspectives. Add technical genius and entrepreneurial drive to a creative mindset, and you get an innovator who may have what it takes to launch a big idea in the world, where it could topple the status quo. We provide guidance, insight, and tools to help make that happen. We can help you identify opportunities for growth and then help you make the most of them. That’s gratifying work. And it leads to rewarding professional relationships. At every step, we flag legal considerations that could make a big difference. At the company formation stage, you could grant yourself legal rights that will help you hold onto your company as you attract investors. If not today, then soon, you’ll need to identify key sources of funding. I can work with you to raise new capital through private placements, an initial public offering, a strategic sale. I’ve handled these and other corporate transactions for tech-based companies in a variety of industries: software and high tech, fintech and financial services, clean and green tech, biotech, video gaming, virtual reality and artificial intelligence, consumer electronics, media, e-commerce, and others. Surprise me – and disrupt the market – with your big idea. I’m here to help.

https://orb-flatworm-3nw8.squarespace.com/meet-the-team/samuel-effron
Previous
Previous

Seed Funding Basics

Next
Next

Key Considerations: Board of Director Composition and Director Recruiting in Early Stage Companies